miR-34a predicts survival of Ewing's sarcoma patients and directly influences cell chemo-sensitivity and malignancy.

Nakatani, Fumihiko

miR-34a predicts survival of Ewing's sarcoma patients and directly influences cell chemo-sensitivity and malignancy. [electronic resource] - The Journal of pathology Apr 2012 - 796-805 p. digital

Publication Type: Journal Article; Research Support, Non-U.S. Gov't

1096-9896

10.1002/path.3007 doi


Antineoplastic Combined Chemotherapy Protocols--therapeutic use
Biomarkers, Tumor--metabolism
Bone Neoplasms--drug therapy
Cell Line, Tumor
Disease-Free Survival
Dose-Response Relationship, Drug
Doxorubicin--pharmacology
Drug Resistance, Neoplasm--genetics
Drug Synergism
Humans
Imidazoles--pharmacology
In Situ Hybridization
Inhibitory Concentration 50
Kaplan-Meier Estimate
MicroRNAs--metabolism
Multivariate Analysis
Oligonucleotide Array Sequence Analysis
Paraffin Embedding
Piperazines--pharmacology
Proportional Hazards Models
Real-Time Polymerase Chain Reaction
Reproducibility of Results
Retrospective Studies
Risk Assessment
Risk Factors
Sarcoma, Ewing--drug therapy
Time Factors
Transfection
Treatment Outcome
Tumor Suppressor Protein p53--genetics
Vincristine--pharmacology